Form D · Other Health Care
Synvitrobio, Inc.
San Leandro, CA · CIK 0001994409
Offering snapshot reported Sep 22, 2023 · SEC filing
- Reported sold
- $17.6M Offering amount: $17.6M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 8, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 22, 2023 | Initial | $17,556,003 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-492808
The Total Amount Sold includes conversion of SAFEs in the aggregate amount of $6,156,008.21.
Source: Form D, filed Sep 22, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Corinna Chen | Director |
| Francisco Dopazo | Director |
| Michael Nemzek | Director, Executive |
| Zachary Sun | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1933 Davis Street, Suite 223
San Leandro, CA, 94577
San Leandro, CA, 94577